Global Vascular Thought Leaders Document Shift toward Individualizing Patient Care in Surgical Bypass
Presentations and Discussions from the Surgical Bypass Summit Available at www.surgicalbypass.com
Gore Announces Positive Results from REDUCE Clinical Study for PFO Closure
Study met its primary endpoint with PFO closure in conjunction with antiplatelet therapy, reducing recurrent stroke by > 75% over antiplatelet therapy alone
Gore Joins Vascular and Endovascular Leaders in Recognizing the 2016 Pioneers in Performance for North America
Leading Practitioners and Researchers from North America Commended for Commitment to Advancing Vascular and Endovascular Therapy
First Patients Enrolled in Gore Thoracoabdominal Aortic Aneurysm Clinical Study
Device offers first and only complete “off-the-shelf” endovascular system specifically designed to treat aortic aneurysms involving visceral branch vessels
Gore Again Named One of the 100 Best Companies to Work For®
Every year since 1998: That’s how long W. L. Gore & Associates has appeared on the Fortune 100 Best Companies to Work For® list
Nominees Announced for 2016 Pioneers in Performance Awards for North America; Online Voting Opens at www.PioneersInPerformance.com
Awards program honors medical specialists advancing therapy and improving patient and clinical performance through active collaboration